Buruli ulcer: An epidemiological update from Japan

Japan is one of the rare non-tropical countries with documented cases of Buruli ulcer (BU). Mycobacterium ulcerans subsp. shinshuense has been identified as the causative agent. The first report of BU in Japan dates back to 1982, with sporadic reports thereafter. Recently, the number of cases has been on the increase, and 50 cases (57.7%) are from the past decade alone, out of a total of 87 cases reported to date. Japan's well-developed healthcare facilities play a crucial role in enabling detailed investigations and providing appropriate treatment for patients, contributing to a favorable prognosis. However, the rarity of the disease results in lack of awareness among healthcare professionals, leading to frequent delays in diagnosis. This article aims to offer an updated overview of BU cases in Japan and to raise awareness of BU among dermatologists and other healthcare professionals in a non-endemic setting.

Authors

Institutions

Publication Details

Journal
The Journal of Dermatology
Published
2024-09-30
DOI
https://doi.org/10.1111/1346-8138.17483
Citations
3
Primary Topic
Mycobacterium research and diagnosis
Type
article
Field-Weighted Citation Impact
1.16

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Buruli ulcer: An epidemiological update from Japan

Rie Yotsu, Toshifumi Takahashi, Mariko Sugawara‐Mikami, Manabu Ato et al.
3 citations
The Journal of Dermatology
Mycobacterium research and diagnosis
1.16
article

Buruli ulcer: An epidemiological update from Japan

Rie Yotsu, Toshifumi Takahashi, Mariko Sugawara‐Mikami, Manabu Ato, Ryo Fukaura, Yoshihiko Hoshino, Noriki Fujimoto, Norihisa Ishii, Yuji Miyamoto, Masashi Akiyama, Chiaki Murase
article en
3 citations

Abstract

Japan is one of the rare non-tropical countries with documented cases of Buruli ulcer (BU). Mycobacterium ulcerans subsp. shinshuense has been identified as the causative agent. The first report of BU in Japan dates back to 1982, with sporadic reports thereafter. Recently, the number of cases has been on the increase, and 50 cases (57.7%) are from the past decade alone, out of a total of 87 cases reported to date. Japan's well-developed healthcare facilities play a crucial role in enabling detailed investigations and providing appropriate treatment for patients, contributing to a favorable prognosis. However, the rarity of the disease results in lack of awareness among healthcare professionals, leading to frequent delays in diagnosis. This article aims to offer an updated overview of BU cases in Japan and to raise awareness of BU among dermatologists and other healthcare professionals in a non-endemic setting.

The Journal of DermatologyVol. 52(1)
Tulane University (US), Shiga University of Medical Science (JP), Zen-Noh (Japan) (JP), National Institute of Infectious Diseases (JP), Miwa Internal Medicine Clinic (JP), National Center for Global Health and Medicine (JP), Nagasaki University (JP), Nagoya University (JP)
Japan Agency for Medical Research and Development, Japan International Cooperation Agency, Japan Society for the Promotion of Science
Good health and well-being
Openalex Percentile: Top 20%
Mycobacterium research and diagnosis
1.16
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.